Benchmarking Adenoma Detection Rates for Colonoscopy: Results From a US-Based Registry

Am J Gastroenterol. 2021 Sep 1;116(9):1946-1949. doi: 10.14309/ajg.0000000000001358.

Abstract

Introduction: Adenoma detection rate (ADR) is highly variable across practices, and national or population-based estimates are not available. Our aim was to study the ADR, variability of rates over time, and factors associated with detection rates of ADR in a national sample of patients undergoing colonoscopy.

Methods: We used colonoscopies submitted to the GI Quality Improvement Consortium, Ltd. registry from 2014 to 2018 on adults aged 50-89 years. We used hierarchical logistic models to study factors associated with ADR.

Results: A total of 2,646,833 colonoscopies were performed by 1,169 endoscopists during the study period. The average ADR for screening colonoscopies per endoscopist was 36.80% (SD 10.21), 44.08 (SD 10.98) in men and 31.20 (SD 9.65) in women. Adjusted to the US population, the ADR was 39.08%. There was a significant increase in ADR from screening colonoscopies over the study period from 33.93% in 2014 to 38.12% in 2018.

Discussion: The average ADR from a large national US sample standardized to the US population is 39.05% and has increased over time.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adenoma / diagnosis*
  • Aged
  • Aged, 80 and over
  • Benchmarking
  • Colonic Neoplasms / diagnosis*
  • Colonoscopy / standards*
  • Early Detection of Cancer / standards*
  • Female
  • Humans
  • Male
  • Mass Screening
  • Middle Aged
  • Quality Improvement
  • Registries
  • United States